SAFWAN GAZNABI
CLEVELAND, OH
Browse related groups: OH Abbott Laboratories All categories
This page merges CMS profile IDs: 7225210, 8334196 (associated profiles published by CMS for the same provider; see the provenance section below).
General Payments — all program years on this page
$3,843.55
- Category: General Payments
- Program years: PY2019–2024
- Record count: 79
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $563.96 across 7 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $563.96 | 7 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Abbott Laboratories | $167.21 | 1 |
| Acerta Pharma LLC | $125.00 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $104.49 | 1 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $94.24 | 1 |
| Janssen Pharmaceuticals, Inc | $73.02 | 3 |
By program year
Records — PY2024 (7)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1078007176 | Janssen Pharmaceuticals, Inc | $25.64 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1078007208 | Janssen Pharmaceuticals, Inc | $20.80 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1078007290 | Janssen Pharmaceuticals, Inc | $26.58 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1080691750 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $94.24 | 12/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1086959847 | Novartis Pharmaceuticals Corporation | $104.49 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104285631 | AstraZeneca Pharmaceuticals LP | $125.00 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1124975216 | Abbott Laboratories | $167.21 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
- Merged CMS profile IDs: 7225210, 8334196
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.